Apimeds Pharmaceuticals US, Inc.

NYSE:APUS

Pharmaceutical Preparations·MATAWAN, NJ

Governanceproxy statements · beneficial ownership

Proxy Statements

2 shown

Filed	Form	Description
2/27/26	DEFM14C	INFORMATION STATEMENT	→
1/16/26	PREM14C	INFORMATION STATEMENT	→

Ownership Filings

35 shown

Filed	Form	Description
11/21/25	4/A	PRIMARY DOCUMENT	→
11/13/25	4	PRIMARY DOCUMENT	→
11/13/25	4	PRIMARY DOCUMENT	→
11/13/25	4	PRIMARY DOCUMENT	→
11/13/25	4	PRIMARY DOCUMENT	→
11/13/25	4	PRIMARY DOCUMENT	→
↓

Apimeds Pharmaceuticals US, Inc. — SlamSEC